Plethora Solutions Holdings Plc Regulatory News (PLE)

20 December 2013

Plethora Solutions Holdings PLC

("Plethora" or the "Company")

CEO Appointment

Plethora Solutions Holdings plc (AIM: PLE) is pleased to announce the appointment of Jamie Gibson, who will join the Board as CEO with effect from 1 January 2014. Mr. Gibson is tasked primarily with driving the Company's commercialisation of PSD502 in Europe, the United States (subject to regulatory approval) and other selected territories. In addition, Mr. Gibson will lead the Company's initiatives on its manufacturing strategy and the extension of the Company's intellectual property platform.

Mr. Gibson has spent most of his professional career working with Jim Mellon for over 17 years at Regent Pacific Group Limited ("Regent Pacific") specialising in corporate finance and direct equity investments. Mr Mellon co-founded Regent Pacific and is Co-Chairman. Mr. Gibson has led many successful investments and divestures with values in excess of US$500 million, including significant fund raisings over his career with Regent Pacific. Regent Pacific is a diversified mining group focused, primarily, on the Asian Pacific region.

Prior to joining Regent Pacific Group, Mr. Gibson worked at Clifford Chance, Coopers & Lybrand and KPMG. Mr. Gibson has a law degree from Edinburgh University.

Jim Mellon Chairman of Plethora said:

"We welcome Jamie whom I have worked with at Regent Pacific for over 17 years; we wish him every success in his new role. We are extremely pleased to have such an experienced team lead our business development activities, which is part of the Company's disciplined approach to increasing shareholder value through the successful commercialisation of PSD502."

Further information that is required to be disclosed with regards to the appointment of Jamie Gibson pursuant to Schedule 2 paragraph (g) of the AIM Rules is set out below.

Jamie Alexander Gibson, aged 47, has or has held within the last five years, the following directorships or partnerships:

Mr. Gibson, Regent Pacific and Clara Cheung, a former executive director were criticised by the Stock Exchange of Hong Kong ("HKSE") on 24 November 2010. According to the HKSE, Mr. Gibson, in his capacity as an executive director of Regent Pacific, had failed to use his best endeavours to procure the company's compliance with a rule in relation to a HKSE listed company purchasing its own shares. Regent Pacific had violated the HKSE's rule when it repurchased its own shares at a price of five per cent. or more above the average closing market price for the five proceeding trading days in 2008.

Mr. Gibson, Regent Pacific and Clara Cheung co-operated openly and promptly with the HKSE, accepted the sanction imposed, further apologised to shareholders and accepted full responsibility for the breaches.

No further disclosures are required under Rule 17 and Schedule 2 paragraph (g) of the AIM Rules for Companies.

-Ends-

Enquiries:

About Plethora:

Plethora is headquartered in the UK and is listed on the London Stock Exchange (AIM: PLE.L). Further information is available at www.plethorasolutions.co.uk 

Plethora is focussed on seeking to launchPSD502 for the treatment of premature ejaculation.

About PSD502 & Premature Ejaculation:

PSD502 is a topical spray for the treatment of premature ejaculation containing lidocaine and prilocaine in a eutectic-like mixture. The Company anticipates launch in 2014.

Premature ejaculation is possibly the most common form of sexual dysfunction in men. Epidemiological studies conducted in the US and in Europe indicate a prevalence of 20 - 30% in men of all ages. There is currently no globally approved and effective pharmaceutical treatment for this condition.

In the absence of any widely approved pharmaceutical therapy with good patient acceptance, the premature ejaculation market offers significant potential for development and growth. An effective drug therapy for premature ejaculation may have a comparable commercial potential to the erectile dysfunction drugs.